Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19152625 | 0.79 | TSHR (0.36) | LMNAGPR3POLBL3MBTL1ALDH1A1 | |
| SCHEMBL23280213 | 0.77 | LMNA (0.32) | LMNAPSMD14GPR3POLBTHRB | |
| SCHEMBL19365233 | 0.77 | GPR3 (0.50) | LMNAGPR3POLBL3MBTL1ALDH1A1 | |
| SCHEMBL20886634 | 0.76 | GPR3 (0.35) | LMNAGPR3POLBL3MBTL1ALDH1A1 | |
| SCHEMBL22368026 | 0.74 | ALDH1A1 (0.50) | LMNAPOLBL3MBTL1ALDH1A1CYP1A2 | |
| SCHEMBL20122222 | 0.74 | KDM4E (0.53) | L3MBTL1ALDH1A1CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL24322601 | 0.73 | ALDH1A1 (0.33) | LMNAPSMD14GPR3ALDH1A1 | |
| SCHEMBL20878494 | 0.73 | GPR3 (0.32) | LMNAPSMD14GPR3ALDH1A1 | |
| SCHEMBL23503054 | 0.73 | PSMD14 (0.33) | LMNAPSMD14POLBTHRBL3MBTL1 | |
| SCHEMBL22360497 | 0.73 | BCHE (0.42) | LMNAPOLBALDH1A1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210202858-A1 | ORGANIC ELECTRIC ELEMENT, DISPLAY PANEL COMPRISING THE SAME AND DISPLAY DEVICE COMPRISING THE SAME | LG DISPLAY CO., LTD. (KR) | 2021-07-01 | — | — | US | disclosed |
| US-20210202860-A1 | ORGANIC ELECTRIC ELEMENT, DISPLAY PANEL COMPRISING THE SAME AND DISPLAY DEVICE COMPRISING THE SAME | LG DISPLAY CO., LTD. (KR) | 2021-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210202860-A1 | ORGANIC ELECTRIC ELEMENT, DISPLAY PANEL COMPRISING THE SAME AND DISPLAY DEVICE COMPRISING THE SAME | EPHA8, L1CAM, OCIAD2 | LMNA 2723/4885PSMD14 3166/4885GPR3 4606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.